Dr. Tadashi Honda
Publication List
1. The Structure of Arjungenin. A New Sapogenin from Terminalia arjuna.
T. Honda, T. Murae, T. Tsuyuki, and T. Takahashi
Chem. Pharm. Bull., 24, 178 (1976).
2. Arjungenin, Arjunglucoside I, and Arjunglucoside II. A New Triterpene and New Triterpene Glucosides from Terminalia arjuna.
T. Honda, T. Murae, T. Tsuyuki, T. Takahashi, and M. Sawai
Bull. Chem. Soc. Jpn., 49, 3213 (1976).
3. Olean-18-ene Derivatives with a 13aH-Configuration
T. Honda, T. Murae, T. Tsuyuki, and T. Takahashi.
Chem. Lett., 1977, 271.
4. 13aH-Olean-18-ene Derivatives. Forced Wolff-Kishner Reduction Products of 19-Oxoolean-12-ene Derivatives.
T. Honda, T. Murae, T. Tsuyuki, and T. Takahashi
Bull. Chem. Soc. Jpn., 51, 884 (1978).
5. A New Triterpene Glucoside from Terminalia arjuna. Arjunglucoside III.
T. Tsuyuki, Y. Hamada, T. Honda, T. Takahashi, and K. Matsushita
Bull. Chem. Soc. Jpn., 52, 3127 (1979).
6. Synthesis of (±)-3,3-Ethylenedioxy-14a-hydroxy-5-picrasene-11,16-dione,
a 14aH-Picrasane Derivative.
T. Honda, T. Murae, S. Ohta, Y. Kurata, H. Kawai, T. Takahashi, A. Itai, and
Y. Iitaka, Chem. Lett., 1981, 299.
7. Structures of Yadanziolides A, B, and C, New Bitter Principles from Brucea javanica.
S. Yoshimura, T Sakaki, M. Ishibashi, T. Tsuyuki, T. Takahashi, K. Matsushita, and
T. Honda
Chem. Pharm. Bull., 32, 4698 (1984).
8. New Quassinoid Glycosides, Yadanziosides A-H, from Brucea javanica.
T. Sakaki, S. Yoshimura, M. Ishibashi, T. Tsuyuki, T. Takahashi, T. Honda, and
T. Nakanishi
Chem. Pharm. Bull., 32, 4702 (1984).
9. Constituents of Seeds of Brucea javanica. Structures of New Bitter Principles, Yadanziolides A, B, C, Yadanziosides F, I, J, and L.
S. Yoshimura, T Sakaki, M. Ishibashi, T. Tsuyuki, T. Takahashi, and T. Honda
Bull. Chem. Soc. Jpn., 58, 2673 (1985).
10. Structures of New Quassinoid Glycosides, Yadanziosides A, B, C, D, E, G, H, and New Quassinoids, Dehydrobrusatol and Dehydrobruceantinol from Brucea javanica (L.) Merr. T. Sakaki, S. Yoshimura, M. Ishibashi, T. Tsuyuki, T. Takahashi, T. Honda, and
T. Nakanishi
Bull. Chem. Soc. Jpn., 58, 2680 (1985).
11. Two New Quassinoid Glycosides, Yadanziosides N and O Isolated from Seeds of Brucea javanica (L.) Merr.
T. Sakaki, S. Yoshimura, T. Tsuyuki, T. Takahashi, T. Honda, and
T. Nakanishi
Tetrahedron Lett., 27, 593 (1986).
12. Structures of Yadanziosides K, M, N, and O, New Quassinoid Glycosides from Brucea javanica (L.) Merr.
T. Sakaki, S. Yoshimura, T. Tsuyuki, T. Takahashi, T. Honda, and
T. Nakanishi
Bull. Chem. Soc. Jpn., 59, 3541 (1986).
13. Yadanzioside P, a New Antileukemic Quassinoid Glycoside from Brucea javanica (L.) Merr with the 3-O-(b-D-Glucopyranosyl)bruceantin Structure.
T. Sakaki, S. Yoshimura, T. Tsuyuki, T. Takahashi, and T. Honda
Chem. Pharm. Bull., 34, 4447 (1986).
14. Preparation of a Tricyclic A-Ring Analog of Quassin.
K. Kurata, H. Hirota, T. Honda, and T. Takahashi
Chem. Pharm. Bull., 35, 837 (1987).
15. Studies on Antitumor Activity of Quassinoids: Synthesis and Antitumor Activity of Novel Ailanthone Analogues.
T. Honda, K. Imao, M. Inoue-Shiraishi, N. Nakatsuka, T. Tatsuoka, T. Nakanishi, and T. Noguchi
J. Pharmacobio-Dyn., 10, s-61 (1987).
16. Stereoselective Synthesis of 9-Hydroxyellipticine Glycosides, Novel and Highly Active Antitumor Agents.
T. Honda, M. Inoue, M. Kato, K. Shima, and T. Shimamoto
Chem. Pharm. Bull., 35, 3975 (1987).
17. Yadanziolide D, a New C19-Quassinoid Isolated from Brucea javanica (L.) Merr.
S. Yoshimura, K. Ogawa, T. Tsuyuki, T. Takahashi, and T. Honda
Chem. Pharm. Bull., 36, 841 (1988).
18. Antitumor Activity of Novel Ailanthone Derivatives in Vitro and in Vivo.
T. Kato, Y. Suzumura, M. Fukushima, T. Honda, T. Nakanishi, and T. Noguchi
Anticancer Res., 8, 573 (1988).
19. Synthesis and Antitumor Activity of Quaternary Ellipticine Glycosides, a Series of Novel and Highly Active Antitumor Agents.
T. Honda, M. Kato, M. Inoue, T. Shimamoto, K. Shima, T. Nakanishi, T. Yoshida, and T. Noguchi
J. Med. Chem., 31, 1295 (1988).
20. Studies on SUN4599 (2-a-L-Arabinopyranosyl-9-hydroxyellipticinium Bromide),
a Novel and Highly Active Antitumor Agent.
T. Honda, M. Kato, T. Shimamoto, M. Inoue, K. Shima, T. Nakanishi, and
T. Noguchi
J. Pharmacobio-Dyn., 12, s-139 (1989).
21. A Novel Antitumor Agent, SUN4599, an Ellipticine Glycoside (1)
- Antitumor Activity against Murine Tumors.
S. Tsukagoshi, T. Tsuruo, T. Nakanishi, T. Honda, T. Noguchi, and K. Nitta
J. Cancer Res. Clin. Oncol., 116, 443 (1990).
22. A Novel Antitumor Agent, SUN4599, an Ellipticine Glycoside (2)
- Effect against Human Tumor Cells.
K. Nitta, S. Fujimoto, H. Tokita, T. Kunimoto, H. Baba, T. Nakanishi, T. Honda, T. Noguchi, and S. Tsukagoshi
J. Cancer Res. Clin. Oncol. , 116, 442 (1990).
23. A Novel Antitumor Agent, SUN4599, an Ellipticine Glycoside (3)
- Mechanism of Action. T. Tsuruo, T. Kunimoto, H. Baba, T. Nakanishi, T. Honda, T. Noguchi,
S. Tsukagoshi, and K. Nitta
J. Cancer Res. Clin. Oncol., 116, 442 (1990).
24. Drug Delivery through Condensation of Two Prodrugs inside Tumor Cells: Direct Observation Using Fluorescence Microscopy.
T. Honda, D. Rideout, M. McCarthy, T. McCracken, and J. Jaworski
Proc. Am. Assoc. Cancer Res., 32, 419 (1991).
25. Structure-Activity Relationships Study on N-Glycosyl Moieties through Model Building of DNA and Ellipticine N-Glycoside Complex.
T. Shimamoto, S. Imajo, T. Honda, S. Yoshimura, and M. Ishiguro
Bioorg. & Med. Chem. Lett., 6, 1331 (1996).